Maxine Smeaton (CEO)

Chief Executive, Maxine Smeaton has been in post for over five years, during which time she has undertaken a major transformation of the charity, culminating in the development of a capacity building programme to radically advance research into epilepsy through investment, collaboration and action. In 2023, Maxine oversaw the charity’s transition to becoming the Epilepsy Research Institute.

Maxine’s roles within the sector have been focused on development, transformation and partnership working. This has included leading significant business and strategy development programmes for organisations such as Royal Mencap Society, Action for Children, and more recently, leading the internationally renowned Blond McIndoe Research Foundation.

Before moving to the charity sector, Maxine worked in the area of large-scale information management strategy and architecture consulting for organisations such as Reuters, Royal Bank of Scotland, Coutts, NatWest and LIFFE. She is a graduate of the Bayes Business School Charity Masters programme.